Newly Elected Republican Senate Majority Leader Opposes Marijuana Legalization, Rescheduling And Industry Banking Access

Senate Republicans on Wednesday elected a new majority leader who not only opposes legalizing marijuana but has also called for a reversal of the Biden administration’s plan to reschedule cannabis and has criticized Democrats for working to increase the industry’s access to banking services.

Thune, who defeated Sens. John Cornyn (R-TX) and Rick Scott (R-FL) in an election for the leadership slot, joined other GOP lawmakers in a letter in July challenging the current administration’s marijuana rescheduling push, urging that the policy proposal be trashed.

The rescheduling rule “fails to provide adequate science and data to support moving marijuana to schedule III and should not have been signed or published,” the letter Thune signed says, calling it “irresponsible” for federal health officials to “make this determination when emerging research shows that there are significant health concerns associated with marijuana use.”

The letter details Thune’s and other Republican lawmakers’ concerns about marijuana’s health effects, suggesting that there is a “clear association between cannabis use and psychosis, anxiety, cognitive failures, respiratory adverse events, cancer, cardiovascular outcomes and gastrointestinal disorders.”

It also claims that “sexual disfunction was twice as high in men who used marijuana” and that “marijuana use among veterans with PTSD was associated with worse PTSD symptoms, more violent behavior, and alcohol use.”

Beyond criticizing cannabis use and policy reform, the letter Thune signed further calls into question whether marijuana has any medical value.

“Medical marijuana dispensaries sell edibles and vapes that come in flavors like passion raspberry, blueberry calm, wild cherry, and sour apple,” it says. “Pretending that these products are medicine that can treat health conditions is doing a disservice to Americans.”

“It remains the case that marijuana has no currently accepted medical use,” Thune and his Republican colleague wrote. “The fact that states have labeled marijuana as ‘medicine’ does not change the nature of the drug… We urge you to withdraw this proposal and maintain marijuana as a schedule I drug.”

Separately, as Senate Democrats moved to advance a marijuana legalization bill in 2021, Thune said that cannabis reform is “something we’ll probably have to grapple with here.” But he’s consistently opposed even modest proposals to allow marijuana industry banking.

Earlier this year, Thune said attaching cannabis banking legislation to an aviation bill would be “a non-starter,” noting that Republican  opposition to the idea is “very strong.”

He called the then-Democratic-controlled House’s proposal to include marijuana banking reform in a large-scale coronavirus relief bill “crazy stuff” in 2020, complaining in a floor speech that the text of the underlying legislation mentions “cannabis” more times than “jobs.”